Current understanding and potential immunotherapy for HIV-associated Squamous Cell Carcinoma of the Anus (SCCA)

World Journal of Surgery

Volumn 33, Issue 4, 2009, Pages 653-660

  Marin Muller, Christian ^a   Li, Min ^a   Chen, Changyi ^a   Yao, Qizhi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; L2E7E6 VACCINE; MITOMYCIN C; MVA E2 VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS VACCINE; WART VIRUS VACCINE;

ANUS CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PATHOGENESIS; PROPHYLAXIS; RECTUM ABDOMINOPERINEAL RESECTION; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; VACCINATION; VERRUCA VULGARIS;

AIDS VACCINES; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; COMORBIDITY; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HIV SEROPOSITIVITY; HUMANS; IMMUNOCOMPROMISED HOST; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; REPRESSOR PROTEINS;

EID: 62549123344     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9835-y     Document Type: Review

References (86)

1. SP Fagan CF Bellows III D Albo 2005 Length of human immunodeficiency virus disease and not immune status is a risk factor for development of anal carcinoma Am J Surg 190 732 735
2. DP Ryan CC Compton RJ Mayer 2000 Carcinoma of the anal canal N Engl J Med 342 792 800
3. A Wexler AM Berson SE Goldstone 2008 Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy Dis Colon Rectum 51 73 81
4. PA Konstantinopoulos HP Schlecht B Bryan 2006 HIV-associated anal squamous cell cancer: an otherwise preventable disease J Clin Oncol 24 4516 4517
5. J Zhang CR Martins ZB Fansler 2005 DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma Clin Cancer Res 11 6544 6549
6. C Oehler-Janne F Huguet S Provencher 2008 HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy J Clin Oncol 26 2550 2557
7. R Tachezy T Jirasek M Salakova 2007 Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology Apmis 115 195 203
8. N Esiashvili J Landry RH Matthews 2002 Carcinoma of the anus: strategies in management Oncologist 7 188 199
9. JM Palefsky EA Holly J Gonzales 1991 Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer Cancer Res 51 1014 1019
10. G Sirera S Videla P Herranz JE Corzo-Delgado 2006 Human papillomavirus and HIV/AIDS Enferm Infecc Microbiol Clin 24 40 46
11. HE Uronis JC Bendell 2007 Anal cancer: an overview Oncologist 12 524 534
12. JM Palefsky EA Holly ML Ralston 1998 High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men AIDS 12 495 503
13. NF Schlecht RD Burk JM Palefsky 2005 Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women J Gen Virol 86 2709 2720
14. CS Nahas O Lin MR Weiser 2006 Prevalence of perianal intraepithelial neoplasia in HIV-infected patients referred for high-resolution anoscopy Dis Colon Rectum 49 1581 1586
15. SR Nadal SH Horta EE Calore CR Manzione 2007 Outcome of treatment of anal squamous cell carcinoma and its precursor in HIV-infected patients Rev Assoc Med Bras 53 365 369
16. M Frisch C Fenger AJ van den Brule 1999 Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses Cancer Res 59 753 757
17. AM Degener L Laino A Pierangeli 2004 Human papillomavirus-32-positive extragenital Bowenoid papulosis (BP) in a HIV patient with typical genital BP localization Sex Transm Dis 31 619 622
18. S Ljubojevic 2006 The human papillomavirus vaccines Acta Dermatovenerol Croat 14 208
19. HU Bernard IE Calleja-Macias ST Dunn 2006 Genome variation of human papillomavirus types: phylogenetic and medical implications Int J Cancer 118 1071 1076
20. SC Nahas CS Nahas EV a Filho 2007 Perianal squamous cell carcinoma with high-grade anal intraepithelial neoplasia in an HIV-positive patient using highly active antiretroviral therapy: case report Sao Paulo Med J 125 292 294
21. M Melbye TR Cote L Kessler 1994 High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group Lancet 343 636 639
22. M Frisch B Glimelius AI van den Brule 1998 Sexually transmitted infection as a cause of anal cancer Ugeskr Laeger 160 7109 7117
23. MM Da Costa CJ Hogeboom EA Holly JM Palefsky 2002 Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant J Infect Dis 185 1229 1237
24. L Giuliani C Ronci D Bonifacio 2008 Detection of oncogenic DNA viruses in colorectal cancer Anticancer Res 28 1405 1410
25. SE Goldstone AZ Kawalek JW Huyett 2005 Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions Dis Colon Rectum 48 1042 1054
26. P Gervaz D Hahnloser BG Wolff 2004 Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients J Gastrointest Surg 8 1024 1030
27. M von Knebel Doeberitz C Rittmuller F Aengeneyndt 1994 Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions J Virol 68 2811 2821
28. T Hiller S Poppelreuther F Stubenrauch T Iftner 2006 Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification Cancer Epidemiol Biomarkers Prev 15 1262 1267
29. T Hiller F Stubenrauch T Iftner 2008 Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation J Med Virol 80 478 483
30. A Duensing A Chin L Wang 2008 Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms Virology 372 157 164
31. G Hu W Liu EG Hanania 1995 Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells Cancer Gene Ther 2 19 32
32. JM Palefsky ML Gillison HD Strickler 2006 Chapter 16: HPV vaccines in immunocompromised women and men Vaccine 24 S140 146
33. JPAWPT Grandhi AF Shields U Vaishampayan 2006 A retrospective review of anal squamous cell carcinoma in HIV positive and HIV negative patients J Clin Oncol 24 4153
34. M Nathan N Hickey L Mayuranathan 2008 Treatment of anal human papillomavirus-associated disease: a long term outcome study Int J STD AIDS 19 445 449
35. CE Pineda JM Berry N Jay 2007 High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients J Gastrointest Surg 11 1410 1415
36. A Herat K Shirato DL Damian 2006 Invasive squamous cell carcinoma arising in refractory perianal Bowen's disease in a HIV-positive individual Australas J Dermatol 47 120 123
37. L Abramowitz D Benabderrahmane P Ravaud 2007 Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors AIDS 21 1457 1465
38. B Vatra I Sobhani T Aparicio 2002 Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis Gastroenterol Clin Biol 26 150 156
39. I Sobhani F Walker T Aparicio 2002 Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa Clin Cancer Res 8 2862 2869
40. A Petter K Heim M Guger 2000 Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women J Gen Virol 81 701 708
41. P Gervaz B Hirschel P Morel 2006 Molecular biology of squamous cell carcinoma of the anus Br J Surg 93 531 538
42. A Kreuter NH Brockmeyer B Hochdorfer 2005 Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection J Am Acad Dermatol 52 603 608
43. I Sobhani F Walker F Roudot-Thoraval 2004 Anal carcinoma: incidence and effect of cumulative infections AIDS 18 1561 1569
44. E Gervaz MD Dauge-Geffroy I Sobhani 1995 Quantitative analysis of the immune cells in the anal mucosa Pathol Res Pract 191 1067 1071
45. K Wilkins R Turner JC Dolev 2006 Cutaneous malignancy and human immunodeficiency virus disease J Am Acad Dermatol 54 189 206
46. C Diamond TH Taylor T Aboumrad 2005 Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy Sex Transm Dis 32 314 320
47. W Adler FC Lee G Wong 2004 Capecitabine, mitomycin C and radiation for HIV patients with anal squamous cell carcinoma J Clin Oncol 22 4239
48. PV Chin-Hong JM Palefsky 2005 Human papillomavirus anogenital disease in HIV-infected individuals Dermatol Ther 18 67 76
49. WE Longo AM Vernava III TP Wade 1994 Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy Ann Surg 220 40 49
50. ND Nigro VK Vaitkevicius B Considine Jr 1974 Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 354 356
51. D Stewart Y Yan IJ Kodner 2007 B Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors? J Gastrointest Surg 11 1744 1751
52. JK Salama LK Mell DA Schomas 2007 Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience J Clin Oncol 25 4581 4586
53. YT You JY Wang CR Changchien 1993 An alternative treatment of anal squamous cell carcinoma: combined radiotherapy and chemotherapy J Surg Oncol 52 42 45
54. R Wadleigh K Dinh J Manning 2006 Low dose mitomycin c, capecitabine and radiation for HIV patients with anal squamous cell carcinoma J Clin Oncol 24 14148
55. ASS Hanna-Morris M Fisher C Cottrill 2003 Chemo-Irradiation for anal squamous cell carcinoma in the era of HAART Antivir Ther 8 944
56. M Chadha EA Rosenblatt S Malamud 1994 Squamous-cell carcinoma of the anus in HIV-positive patients Dis Colon Rectum 37 861 865
57. M Flam M John TF Pajak 1996 Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 2527 2539
58. R Roohipour S Patil KA Goodman 2008 Squamous-cell carcinoma of the anal canal: predictors of treatment outcome Dis Colon Rectum 51 147 153
59. J Ahn B Cho H Choi 2006 Chemoradiation and maintenance chemotherapy with cisplatin and 5-fluorouracil in anal squamous cell carcinoma J Clin Oncol 24 14057
60. BC Cho JB Ahn J Seong 2008 Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients BMC Cancer 8 8
61. D Peiffert M Giovannini M Ducreux 2001 High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study Ann Oncol 12 397 404
62. E de Bree S van Ruth LG Dewit FA Zoetmulder 2007 High risk of colostomy with primary radiotherapy for anal cancer Ann Surg Oncol 14 100 108
63. DE Schiller BJ Cummings S Rai 2007 Outcomes of salvage surgery for squamous cell carcinoma of the anal canal Ann Surg Oncol 14 2780 2789
64. JP Spano D Costagliola C Katlama 2008 AIDS-related malignancies: state of the art therapeutic challenges J Clin Oncol 26 1 9
65. EY Chiao TP Giordano P Richardson HB El-Serag 2008 Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era J Clin Oncol 26 474 479
66. N Mathieu T Aparicio F Roudot-Thoraval 2007 Incidence of SCCA is increasing promoted by HIV infection J Clin Oncol 25 4632
67. LA Panther HP Schlecht BJ Dezube 2005 Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients AIDS Read 15 79 82
68. CE Pineda JM Berry N Jay 2008 High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience Dis Colon Rectum 51 829 835
69. WC Mathews A Sitapati JC Caperna 2004 Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program J Acquir Immune Defic Syndr 37 1610 1615
70. SE Goldstone AZ Kawalek RN Goldstone AB Goldstone 2008 Hybrid capture II detection of oncogenic human papillomavirus: a useful tool when evaluating men who have sex with men with atypical squamous cells of undetermined significance on anal cytology Dis Colon Rectum 51 1130 1136
71. H Scott J Khoury BA Moore S Weissman 2008 Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic Sex Transm Dis 35 197 202
72. CA Anderson AM Boller CJ Richardson 2004 Anal condyloma: a comparison between HIV positive and negative patients Am Surg 70 1014 1018
73. B Klencke M Matijevic RG Urban 2002 Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101 Clin Cancer Res 8 1028 1037
74. B Devaraj BC Cosman 2006 Expectant management of anal squamous dysplasia in patients with HIV Dis Colon Rectum 49 36 40
75. R Cubas M Li C Chen Q Yao 2007 Colorectal cancer: new advances in immunotherapy Cancer Biol Ther 6 11 17
76. M Stanley DR Lowy I Frazer 2006 Prophylactic HPV vaccines: underlying mechanisms Vaccine 24 S106 113
77. CM Huang 2008 Human papillomavirus and vaccination Mayo Clin Proc 83 701 706
78. FUTURE II Study Group 2007 Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection J Infect Dis 196 1438 1446
79. SM Garland M Hernandez-Avila CM Wheeler 2007 Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 1928 1943
80. J Paavonen D Jenkins FX Bosch 2007 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Lancet 369 2161 2170
81. A Hildesheim R Herrero S Wacholder 2007 Effect of human papillomavirus 16/18 L1 virus-like particle vaccine among young women with preexisting infection: a randomized trial JAMA 298 743 753
82. R Gambhira PE Gravitt I Bossis 2006 Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species Cancer Res 66 11120 11124
83. P Ohlschlager M Pes W Osen 2006 An improved rearranged human papillomavirus type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response Vaccine 24 2880 2893
84. E Garcia-Hernandez JL Gonzalez-Sanchez A Andrade-Manzano 2006 Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine Cancer Gene Ther 13 592 597
85. AM Kaufmann JD Nieland I Jochmus 2007 Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3) Int J Cancer 121 2794 2800
86. JB Koorstra SR Hustinx GJ Offerhaus A Maitra 2008 Pancreatic carcinogenesis Pancreatology 8 110 125